welcome
CNBC

CNBC

Health

Health

Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms

CNBC
Summary
Nutrition label

82% Informative

U.S. production in the pharmaceutical industry has shrunk significantly in recent decades due to lower costs for labor and other parts of the process in countries like China and some European nations.

It's unclear when Trump could announce pharmaceutical-specific tariffs, or if the new executive order changes those plans.

Production of most of the active ingredients in medicines has moved to China and other countries.